Biomedica participated n in the fourth edition of BIO-Europe Spring, taking place in the vibrant city of Barcelona. From March 18 to 20, 2024, this premier conference brought together professionals, startups, and investors from the biotechnology and pharmaceutical industry. The event presented incredible lineup of innovative discussions, key networking opportunities, and a platform to showcase groundbreaking advancements.

From May 21st to 23rd, 2024, the vibrant city of Tel Aviv hosted Biomed Israel 2024 — an unmissable event for industry leaders, innovators, and researchers. Biomedica’s team was thrilled to participate. Dmitry Klimchuk, our esteemed Regional Head for Israel & APAC, was there throughout the conference to discuss our projects and explore potential partnership opportunities.

From May 16th to 19th, 2024, our team participated in the MENA Congress for Rare Diseases, held at the Beach Rotana in Abu Dhabi, United Arab Emirates. The event unites diverse stakeholders committed to advancing rare disease care across the Middle East and North African (MENA) region.

In May 2024, Biomedica participated in the Abu Dhabi Global Healthcare Week (ADGHW). Supported by the Abu Dhabi Department of Health, the event brought together healthcare leaders, policymakers, and stakeholders from around the world.

Our Biomedica team was thrilled to be a sponsor and a presenter at the Rare Disease Conference 2024 in Philadelphia. As key stakeholders in the field, we are committed to advancing orphan therapeutics and fostering powerful partnerships within the rare disease community.

We are excited to share more about Biomedica’s active involvement in the recently concluded BIO International Convention 2024 held in sunny San Diego. As a leading player in the biotechnology industry, we joined forces with over 19.500 attendees from 70 countries during this four-day event, which took place from June 3rd to June 6th, 2024.